A multi-responsive biomimetic nano-complex platform for enhanced gene delivery
Source abstract
Abstract
RNA interference (RNAi) is widely regarded as a promising technology for disease treatment, yet one major obstacle for its clinical application is the lack of enhanced siRNA delivery vehicles to circumvent complex extra- and intracellular barriers. By integrating unique peculiarities of thioglycolic acid conjugated chitosan nanoparticles (TCS NPs), biomimetic transfersomes (T) and amphiphilic hyaluronic acid (HA-GMS), a novel nano-complex was prepared, where vascular endothelial growth factor (VEGF) siRNA loaded TCS NPs were cloaked by transfersomes with HA-GMS assembled on the surface (HT-TCS-siRNA NPs). The nano-complex provided superior siRNA protection and desirable stability at pH 7.4 and 6.5 (mimicking tumor tissue) and exerted proton sponge effects at acidic pH 5.0 (mimicking endo/lysosomes). The TCS NPs were stable at pH 5.0 but disintegrated in the presence of 10 mM glutathione (GSH) at pH 7.4 (mimicking tumor cytosol), which was favorable to release siRNA to the cytoplasm. In vitro cell uptake and gene silencing assays exhibited enhanced intracellular siRNA accumulation and VEGF silencing efficacy of HT-TCS-siRNA NPs in HeLa cells. The enhanced gene delivery capacity of the multi-responsive biomimetic nano-complex gives them potential for application in cancer therapy.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Marine Life Science
Ocean University of China
Qingdao
P. R. China
Graduate School Biotechnology
Korea University
Seoul 136-701
South Korea
Funding
National Natural Science Foundation of China
References (45)
Show source-provided references
1. Feng · Biomaterials · 2014 · 35 · 502810.1016/j.biomaterials.2014.03.012 ↗
2. Tseng · Adv. Drug Delivery Rev. · 2009 · 61 · 72110.1016/j.addr.2009.03.003 ↗
3. Resnier · Biomaterials · 2013 · 34 · 642910.1016/j.biomaterials.2013.04.060 ↗
4. Yin · Nat. Rev. Genet. · 2014 · 15 · 54110.1038/nrg3763 ↗
5. Hickerson · J. Invest. Dermatol. · 2011 · 131 · 103710.1038/jid.2010.426 ↗
6. Nair · J. Am. Chem. Soc. · 2014 · 136 · 1695810.1021/ja505986a ↗
7. Boisguerin · Adv. Drug Delivery Rev. · 2015 · 87 · 5210.1016/j.addr.2015.02.008 ↗
8. Asai · Biochem. Biophys. Res. Commun. · 2014 · 444 · 59910.1016/j.bbrc.2014.01.107 ↗
9. Schneider · Mol. Ther.–Nucleic Acids · 2012 · 1 · e4610.1038/mtna.2012.39 ↗
10. Cuellar · Nucleic Acids Res. · 2015 · 43 · 118910.1093/nar/gku1362 ↗
11. Rosi · Science · 2006 · 312 · 102710.1126/science.1125559 ↗
12. Rozema · Proc. Natl. Acad. Sci. U. S. A. · 2007 · 104 · 1298210.1073/pnas.0703778104 ↗
13. Nuhn · Biomacromolecules · 2014 · 15 · 411110.1021/bm501148y ↗
14. Akinc · Nat. Biotechnol. · 2008 · 26 · 56110.1038/nbt1402 ↗
15. Semple · Nat. Biotechnol. · 2010 · 28 · 17210.1038/nbt.1602 ↗
16. Conwell · Mol. Ther. · 2008 · 16 · 37010.1038/sj.mt.6300356 ↗
17. Wang · J. Controlled Release · 2011 · 151 · 9510.1016/j.jconrel.2010.12.011 ↗
18. Huang · Curr. Gene Ther. · 2012 · 12 · 27510.2174/156652312802083576 ↗
19. Li · Biomaterials · 2008 · 29 · 361710.1016/j.biomaterials.2008.05.020 ↗
20. Srinivasan · Mol. Ther. · 2006 · 14 · 19210.1016/j.ymthe.2006.03.010 ↗
21. Singh · ACS Nano · 2008 · 2 · 104010.1021/nn8000565 ↗
22. Tezgel · J. Colloid Interface Sci. · 2018 · 510 · 4510.1016/j.jcis.2017.09.045 ↗
23. Van den Bossche · Biomaterials · 2011 · 32 · 308510.1016/j.biomaterials.2010.12.043 ↗
24. Ito · Cancer Lett. · 2004 · 212 · 16710.1016/j.canlet.2004.03.038 ↗
25. Tarahovsky · Biophys. J. · 2004 · 87 · 105410.1529/biophysj.104.042895 ↗
26. El Zaafarany · Int. J. Pharm. · 2010 · 397 · 16410.1016/j.ijpharm.2010.06.034 ↗
27. Chan · Biomaterials · 2012 · 33 · 492810.1016/j.biomaterials.2012.03.038 ↗
28. Kong · Carbohydr. Polym. · 2017 · 169 · 34110.1016/j.carbpol.2017.03.090 ↗
29. Chen · ACS Appl. Mater. Interfaces · 2016 · 8 · 2245710.1021/acsami.6b05041 ↗
30. Wang · Acta Biomater. · 2015 · 23 · 13610.1016/j.actbio.2015.05.028 ↗
31. Zuo · Int. J. Biol. Macromol. · 2017 · 104 · 15710.1016/j.ijbiomac.2017.06.020 ↗
32. Zhao · Carbohydr. Polym. · 2016 · 136 · 30710.1016/j.carbpol.2015.09.049 ↗
33. Kong · Chem. Commun. · 2015 · 51 · 145310.1039/C4CC08746A ↗
34. Hu · Proc. Natl. Acad. Sci. U. S. A. · 2011 · 108 · 1098010.1073/pnas.1106634108 ↗
35. Fang · Nano Lett. · 2014 · 14 · 218110.1021/nl500618u ↗
36. Malmo · J. Controlled Release · 2012 · 158 · 26110.1016/j.jconrel.2011.11.012 ↗
37. Yang · ACS Appl. Mater. Interfaces · 2017 · 9 · 1220310.1021/acsami.6b16556 ↗
38. Liu · Biomaterials · 2007 · 28 · 128010.1016/j.biomaterials.2006.11.004 ↗
39. de Fougerolles · Nat. Rev. Drug Discovery · 2007 · 6 · 44310.1038/nrd2310 ↗
40. Park · Biomaterials · 2010 · 31 · 525810.1016/j.biomaterials.2010.03.018 ↗
41. Mellman · Annu. Rev. Cell Dev. Biol. · 1996 · 12 · 57510.1146/annurev.cellbio.12.1.575 ↗
42. Huotari · EMBO J. · 2011 · 30 · 348110.1038/emboj.2011.286 ↗
43. Khalil · Pharmacol. Rev. · 2006 · 58 · 3210.1124/pr.58.1.8 ↗
44. Yoon · Biomaterials · 2012 · 33 · 398010.1016/j.biomaterials.2012.02.016 ↗
45. Hadj-Slimane · Biochimie · 2007 · 89 · 123410.1016/j.biochi.2007.06.012 ↗